|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.41 CNY | -1.41% |
|
+6.73% | -5.46% |
Aurisco Pharmaceutical Co.,Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 552.65 million compared to CNY 508.94 million a year ago. Net income was CNY 95.9 million compared to CNY 116.74 million a year ago.
Basic earnings per share from continuing operations was CNY 0.24 compared to CNY 0.29 a year ago. Diluted earnings per share from continuing operations was CNY 0.24 compared to CNY 0.29 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -5.46% | 1.37B | |
| +33.25% | 699B | |
| +28.59% | 571B | |
| -3.55% | 364B | |
| +18.16% | 326B | |
| +4.36% | 286B | |
| +14.81% | 236B | |
| +4.93% | 198B | |
| -9.78% | 194B | |
| -3.69% | 149B |
AURISCO PHARMACEUTICAL CO.,LTD. 
